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Introduction
A 58 year old woman was referred for functional and con-
trast enhanced cardiovascular magnetic resonance (CMR)
scan to evaluate a left atria mass reported on echocardio-
gram. The patient had history of atypical chest pain and
prior breast cancer.
Purpose
Evaulation of left atria mass possible wall attachment and
tissue chacterization
Methods
Cardiac MR was performed on a 1.5 T, Philips Achieve,
using a 5-element phased-array surface coil. Survey
images revealed an abnormal structure near the left atrial
inferior wall. Basic functional CMR views were performed
to demonstrate the mass orientation. The optimal imag-
ing plane, short axis, was selected for T1 and T2 weighted
dual inversion recovery black blood (dualIR) images with
and without fat suppression were acquired to characterize
the tissue of the abnormal mass. Cine CMR images
(steady state free precession sequence) demonstrated the
mass attached to the inferior septal wall. Perfusion study
of the atria in short axis plane was performed with 8 ml of
gadolinium with rate of 5 ml/sec. No perfusion of the
mass was seen. An additional injection of 32 ml of gado-
linium at a rate of 1 ml/sec was performed. Post T1 dualIR
images noted no enhancement of the mass. Post 3D
hyper-enhancement in multiple planes was performed No
hyper-enhancement was observed on the delayed
enhancement (segmented inversion recovery fast gradient
echo sequence images).
Results
The mass is globutated with a necrotic center and sur-
rounded with fluid. No enhancement of the mass with
gadolinium, no perfusion to the mass or hyper-enhance-
ment. Subsequently, the mass was removed and biopsy
results are pending.
Conclusion
CMR is an excellent tool to evaluate abnormal heart struc-
tures and characterize myocardial tissue none invasively.
The ability to use multiple planes with high resolution
plus image surrounding structures enables CMR to elimi-
nate obstacles inherent in echocardiography.
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